Leucovorin is now approved for cerebral folate deficiency months after FDA Commissioner Marty Makary claimed the decades-old generic drug had promise for treating autism. The FDA’s review was based on published literature and real-world evidence.
The post FDA Drug Approval Marks a First for a Disease — But It’s Not Autism appeared first on MedCity News.
